PubMed Health⌕ Search

PubMed · 12378138

[Doping in high-level athletes].

Abstract

Recent doping affairs clearly demonstrate that all sports are concerned, leading to a generalized suspicion concerning champions and their performance. Many athletes struggling to reach their own personal goals have the unacceptable impression that they cannot compete fairly with competitors who are presumably (or effectively) doped. This situation may easily lead to deviant behavior. The sincerity of many high-level athletes when they discuss doping is very questionable in light of the notoriety and financial aspect linked with success. Public image is all important.Unfortunately, at this level is appears to be utopic to assume preventive measures would be effective. Several factors are involved Taking into consideration these different elements, one could be rather pessimistic concerning the eradication of doping in high-level athletes. There could even be a risk of seeing a trend towards public acceptance of more or less "tolerated" doping among professional athletes, similar to what is observed in the United States. It might be preferable to concentrate efforts on education and prevention in the young population.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B Chalchat. 2002. [Doping in high-level athletes].. https://pubmed.ncbi.nlm.nih.gov/12378138/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Recommended criteria for the mass spectrometric identification of target peptides and proteins (<8 kDa) in sports drug testing.

Mass spectrometry has become an invaluable tool for the identification of prohibited peptide hormones and proteins in doping control analysis. Regulatory authorities have established criteria for identifying banned drugs in doping control specimens, but these criteria do not address the specific issues for high molecular weight protein drugs such as molecular weight determination of multiply charged molecules, analysis of chemically or enzymatically derived degradation products, identification of amino acid sequence tags, etc. Technical considerations such as sample preparation methods (e.g. immunoaffinity purification), resulting analytes (e.g. intact compounds vs. chemically or enzymatically derived peptides), ionization modes, analyzer resolution, and the information provided by respective techniques are discussed in light of sports drug testing requirements using typical application examples.

Doping in Sports↗